Trial Profile
A phase II, multi-centre, randomised, double-blind, placebo-controlled, parallel group, proof of concept study to compare the efficacy, safety and tolerability of PSD502 [lidocaine/prilocaine], delivered topically onto the upper vagina and cervix, to placebo in controlling discomfort/pain intensity in subjects undergoing outpatient hysteroscopy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2022
Price :
$35
*
At a glance
- Drugs Lidocaine/prilocaine (Primary)
- Indications Procedural pain
- Focus Therapeutic Use
- Sponsors Plethora Solutions
- 28 Feb 2008 New trial record.